Zolpidem and driving impairment--identifying persons at risk.
Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA.
Ronald H
RH
Farkas
Ellis F
EF
Unger
Robert
R
Temple
D001334:Automobile Driving; D003692:Delayed-Action Preparations; D017277:Drug Approval; D005260:Female; D006207:Half-Life; D006801:Humans; D006993:Hypnotics and Sedatives / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics; D008297:Male; D011725:Pyridines / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics; D018570:Risk Assessment; D012737:Sex Factors; D007319:Sleep Initiation and Maintenance Disorders / Q000188:drug therapy*; D014481:United States; D014486:United States Food and Drug Administration; D000077334:Zolpidem
D003692:Delayed-Action Preparations; D006993:Hypnotics and Sedatives; D011725:Pyridines; D000077334:Zolpidem